Today's top medical abstracts
Pharmacy
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Pharmacy
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Medicine
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor


testArticles: Drug Trials
Latest (3) Month's Top Read  
Receive daily email updates on Drug Trials


EpiCept Releases New Ceplene AML Data Demonstrating Leukemia Free Survival as Predictor of Improved Overall Survival
Corporate News Releases, 06/16/08

The Power of Hypothesis
BioPharm, 06/13/08

Roche moves investigational diabetes drug, taspoglutide, into phase iii clinical trials
Roche, 06/13/08
Sponsor


Ofatumumab in subcutaneous study in rheumatoid arthritis
Genmab, 06/13/08

Biovest Reports Blinded Results for Phase 3 Study Evaluating Anti-Cancer Vaccine, BiovaxID(R), which Shows 100% Difference in Disease-Free Survival at 36 Months in the Comparative Arms
Corporate News Releases, 06/13/08

Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
Corporate News Releases, 06/13/08

Phase 3 Data Show Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-TNF Agents
Corporate News Releases, 06/13/08

Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
Amylin Pharmaceuticals, 06/12/08

Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
Amylin Pharmaceuticals, 06/12/08

A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
New England Journal of Medicine, 06/12/08
Receive daily email updates on Drug Trials
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
250 Available Pages
First    Prev    6      7      8      9      10      11      12      13      14      15      Next      Last
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.